IRIS
ARTESE, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.586
AS - Asia 1.791
EU - Europa 1.100
SA - Sud America 328
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 5.846
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.490
SG - Singapore 798
CN - Cina 490
IT - Italia 480
BR - Brasile 256
IN - India 200
DE - Germania 181
VN - Vietnam 175
GB - Regno Unito 111
FI - Finlandia 93
SE - Svezia 82
CA - Canada 70
UA - Ucraina 51
AR - Argentina 36
HK - Hong Kong 26
EE - Estonia 20
ES - Italia 17
ID - Indonesia 16
BD - Bangladesh 14
JP - Giappone 14
MX - Messico 14
IQ - Iraq 13
NL - Olanda 13
ZA - Sudafrica 13
EC - Ecuador 10
FR - Francia 10
CZ - Repubblica Ceca 8
CO - Colombia 7
TR - Turchia 7
EU - Europa 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
IR - Iran 4
MA - Marocco 4
PE - Perù 4
PL - Polonia 4
AL - Albania 3
CL - Cile 3
GT - Guatemala 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
PY - Paraguay 3
RU - Federazione Russa 3
TW - Taiwan 3
VE - Venezuela 3
AF - Afghanistan, Repubblica islamica di 2
AT - Austria 2
CY - Cipro 2
DK - Danimarca 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
MN - Mongolia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
PW - Palau 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 5.846
Salva come PNG Salva come JPEG
Città #
Dallas 566
Chandler 336
Singapore 220
Ashburn 182
Santa Clara 160
Munich 153
Hefei 145
Bengaluru 144
Milan 130
Lawrence 124
Princeton 124
London 75
Ho Chi Minh City 70
Wilmington 70
Beijing 62
Chicago 58
Helsinki 55
Ottawa 54
Des Moines 46
Catanzaro 40
Hanoi 36
Los Angeles 29
Turku 28
Shanghai 26
Hong Kong 25
São Paulo 25
Washington 19
Boardman 16
Brooklyn 16
Guangzhou 16
Pune 15
San Francisco 15
New York 13
Rome 13
Shenzhen 11
Tokyo 11
Curitiba 10
Redmond 10
Johannesburg 9
Norwalk 9
Biên Hòa 8
Casoria 8
Chennai 8
Olomouc 8
Phoenix 8
Rio de Janeiro 8
San Nicola Manfredi 8
Brasília 7
Cagliari 7
Haiphong 7
Naples 7
Boston 6
Crotone 6
Guayaquil 6
Hanover 6
Jyväskylä 6
Messina 6
Seattle 6
Weihai 6
Catania 5
Charlotte 5
Columbus 5
Denver 5
Luni 5
Montevideo 5
Montreal 5
Palermo 5
Redwood City 5
San Mateo 5
The Dalles 5
Toronto 5
Wuhan 5
Amsterdam 4
Anagni 4
Atlanta 4
Aversa 4
Council Bluffs 4
Da Nang 4
Dongyang 4
Erbil 4
Heidesheim 4
Hải Dương 4
Jiaxing 4
Lima 4
Porto Alegre 4
Ribeirão Preto 4
Santander 4
Siena 4
Stockholm 4
Thái Bình 4
Treviso 4
Vallefiorita 4
Afragola 3
Amman 3
Avola 3
Bari 3
Bogotá 3
Bonn 3
Buenos Aires 3
Castrovillari 3
Totale 3.467
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 196
A Candidate multi-targeting approach to block the CD98hc oncoprotein 94
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 86
GBPM: applicazione al docking molecolare 83
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 78
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 74
A Computational pathway toward the rational design of azinomycin analogues 72
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations 71
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 70
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 69
Back Cover: Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement (ChemMedChem 16/2016) 68
Chemioterapici antifungini 68
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 68
Identification and Characterization of New DNA G-Quadruplex Binders Selected by a Combination of Ligand and Structure-Based Virtual Screening Approaches 64
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 63
Molecular recognition of a carboxy pyridostatin towards G-quadruplex structures: why does it prefer RNA? 62
A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences 62
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 62
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 60
Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors 59
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 58
Computer-based techniques for lead identification and optimization II: Advanced search methods 57
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 57
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures 56
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 55
Characterization of the role of two additional HIV-1 reverse transcriptase mutations in the regulation of NNRTI resistance 55
CoMFA studies of non covalent monoamine oxidase inhibitors 55
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 54
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 53
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 53
Comparison of molecular dynamics simulations carried out on wild type and mutants of HIV-1 reverse transcriptase 53
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 52
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 52
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders 51
Characterization and structural analysis of HIV-1 integrase conservation 51
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 51
Identification and Structural Characterization of Novel Genetic Elements in HIV-1 - V3 Loop Regulating Co-Receptor Usage 50
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 50
Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach 50
Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics 50
Natural products extracted from fungal species as new potential anti-cancer drugs: A structure-based drug repurposing approach targeting HDAC7 49
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 48
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 47
From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds 47
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures 47
Computer-based techniques for lead identification and optimization i: Basics 47
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 46
Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620 46
GBPM analysis of HIV-1 reverse transcriptase–DNA crystallographic complexes focused on the enzyme conserved regions of HAART-treated patients 46
Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients 45
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 44
Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors 43
Identification of new G-quadruplex binders by combined virtual screening approaches. 43
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors 42
Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders 42
Dinamica molecolare di complessi della proteasi di HIV-1: influenza di mutazioni associate a resistenza sulla ricognizione molecolare 42
Computational analysis of HIV-1 reverse transcriptase complexes 42
Composti per il G-quadruplex a struttura naftilimmidica 42
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods 42
Indagine statistica sulla diffusione nell’Industria farmaceutica italiana di tecnologie computazionali avanzate orientate alla progettazione di nuovi farmaci 41
Progettazione razionale di agenti bisalchilanti del DNA analoghi delle azinomicine 41
Studi computazionali su modelli di Trascrittasi Inversa del virus HIV 40
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 39
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 39
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase 39
Conformational analysis of bioactive conformations in the drug discovery process 39
Metodi computazionali e nutraceutica 39
Conformation and stability of intramolecular telomeric g-quadruplexes: sequence effects in the loops 38
An overview on olfaction in the biological, analytical, computational, and machine learning fields 38
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 37
Computational study on DNA G-quadruplex binding compounds 37
Design and Synthesis of a (N-Alkylaminoalkyl-Substituted) Arylalkenylamide Drug Discovery Library 37
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 37
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 36
Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery? 36
Computer-based techniques for lead identification and optimization I: Basics 35
High-throughput lipophilicity screening of opioid-like analgesics: validation of computational methods by means of RP-HPLC analysis 35
Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold 35
Computational approaches for discovery and optimization of G-quadruplex binders 35
Docking e virtual screening su composti naturali: esempi su quercitina e cucurbitacina 34
Structure-Based Virtual Screening of Novel Natural Alkaloid Derivatives as Potential Binders of h-telo and c-myc DNA G-Quadruplex Conformations 34
Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies 34
Docking comparativo nello sviluppo di ligandi per il DNA G-quadruplex 34
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir containing regimens 34
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance 34
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T). 34
Hit identification and biological evaluation of anticancer pyrazolo-pyrimidines endowed with anti-inflammatory activity 33
Dependence of DNA sequence selectivity and cell cytotoxicity on azinomycin A and B epoxyamide stereochemistry 33
Molecular Recognition Of Dna G-Quadruplex Ligands By Different Docking Methods 33
Molecular interaction fields in drug discovery: recent advances and future perspectives 33
Progettazione razionale e sintesi di prodotti di semplificazione molecolare delle azinomicine 33
Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance 32
Hit identification of novel DNA-quadruplex ligands 32
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral treated HIV-1 infected patients, all naïve to integrase inhibitors 32
Rational drug design of DNA cross-linking agents 32
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors 32
Structure-based pharmacophore modeling of DNA G-Quadruplex ligand-complexes. 32
STATISTICAL ANALISYS OF DRUG DESIGN COMPUTATIONAL TECNIQUES AMONG THE RESEARCH GROUPS IN ITALY 31
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 31
Fluorenone derivatives designed as selective binders of DNA G-Quadruplex 31
Totale 4.883
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 20 23 4 16 13 8 4
2021/2022331 4 2 10 64 23 6 14 80 22 33 69 4
2022/20231.003 253 48 46 72 111 72 9 70 156 59 83 24
2023/2024513 72 57 46 31 33 152 12 45 4 21 16 24
2024/20251.709 204 143 65 59 117 199 92 66 221 119 155 269
2025/20262.067 172 358 650 488 307 92 0 0 0 0 0 0
Totale 5.939